May 3, 2023
May 3, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that our innovative in vitro diagnostic test, METAglut1™ has been recommended for coverage in […]
September 16, 2021
September 16, 2021. [NEWS] Company Lisses et Paris, 16 septembre 2021. Sebia, leader mondial du diagnostic in vitro (DIV) dans le domaine du myélome multiple et des […]
June 19, 2021
June 19, 2021. [NEWS] Company ; METAglut1™ We were thrilled to attend the 3rd European Conference on GLUT1 Deficiency, which took place virtually, and during which […]
June 12, 2017
June 12, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that the results of our first study on our innovative in vitro diagnostic test […]
February 2, 2017
February 2, 2017. [NEWS] Company ; METAglut1™ We are thrilled to announce a significant milestone following our successful fundraising in Q4 2016: in partnership with CERBA […]
November 7, 2016
November 7, 2016. [NEWS] Company Paris, November 7, 2016. The Cerba HealthCare Group and METAFORA biosystems are to cooperate in the deployment of METAFORA proprietary technology in the […]
